Royal Bank of Canada’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.13M | Buy |
|
|||||
|
2025
Q1 | $482K | Buy |
|
|||||
|
2024
Q4 | $295K | Sell |
|
|||||
|
2024
Q3 | $610K | Buy |
|
|||||
|
2024
Q2 | $354K | Buy |
|
|||||
|
2024
Q1 | $165K | Sell |
|
|||||
|
2023
Q4 | $400K | Buy |
|
|||||
|
2023
Q3 | $134K | Buy |
|
|||||
|
2023
Q2 | $116K | Buy |
|
|||||
|
2023
Q1 | $61K | Sell |
|
|||||
|
2022
Q4 | $60K | Buy |
|
|||||
|
2022
Q3 | $7K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $71K | Sell |
|
|||||
|
2021
Q4 | $345K | Buy |
|
|||||
|
2021
Q3 | $85K | Buy |
|
|||||
|
2021
Q2 | $149K | Buy |
|
|||||
|
2021
Q1 | $86K | Buy |
|
|||||
|
2020
Q4 | $24K | Buy |
|
|||||
|
2020
Q3 | $10K | Hold |
|
|||||
|
2020
Q2 | $9K | Buy |
|
|||||
|
2020
Q1 | $0 | Sell |
|
|||||
|
2019
Q4 | $8K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $3K | Sell |
|
|||||
|
2018
Q3 | $5K | Buy |
|
|||||
|
2018
Q2 | $3K | Buy |
|
|||||
|
2018
Q1 | $2K | Buy |
|
|||||
|
2017
Q4 | $1K | Sell |
|
|||||
|
2017
Q3 | $13K | Buy |
|
|||||
|
2017
Q2 | $1K | Sell |
|
|||||
|
2017
Q1 | $3K | Sell |
|
|||||
|
2016
Q4 | $8K | Buy |
|
|||||
|
2016
Q3 | $4K | Buy |
|